Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48).
Ruff
Christian T
CT
TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. cruff@partners.org
Giugliano
Robert P
RP
Antman
Elliott M
EM
Crugnale
Sharon E
SE
Bocanegra
Tomas
T
Mercuri
Michele
M
Hanyok
James
J
Patel
Indravadan
I
Shi
Minggao
M
Salazar
Dan
D
McCabe
Carolyn H
CH
Braunwald
Eugene
E